Entest BioMedical's (OTCQB: ENTB) Subsidiary Zander

New Post Public Reply Private Reply Replies (0) Message Board
MicroCapStocksRock SHEEPWOLF #17035
208
Entest BioMedical's (OTCQB: ENTB) Subsidiary Zander Therapeutics, Inc., Reports Its Series A Compounds Suppressed the Production of Multiple Cytokines Known to be Involved in Inflammation With No Toxicity In Canine Studies

Company sees results demonstrating a major step forward in its small molecule anti-inflammatory drug development for veterinary use

SAN DIEGO, June 13, 2017 /PRNewswire/ --

Entest BioMedical Inc.'s (OTCQB: ENTB) subsidiary, Zander Therapeutics, Inc. has tested compounds that act on human cells in suppressing the immune system in a small amount of dog blood. The results indicate that one of the compounds, termed Series A, suppressed the production of multiple cytokines known to be involved in inflammation by activating checkpoint NR2F6. These include IL-17a, IL-1, IL-2, TNF-α and IFN-ɣ production from activated peripheral blood mononuclear cells in a non-toxic manner.

"Creating a small molecule drug that targets inflammation through activation of NR2F6 is a completely novel method and one which has great promise to improve the quality of life of many pets," says Dr. Harry Lander, President and Chief Scientific Officer of Zander. "we are continuing to improve this particular drug by making it more potent. We found excellent efficacy at concentrations 50 fold lower than where toxicity is seen, but we want to do even better."

Zander is continuing similar experiments testing other compounds and will also begin to test anti-cancer small molecule compounds in the coming months.

About Zander Therapeutics Inc. and Entest BioMedical Inc.:

Zander Therapeutics is a subsidiary of Entest BioMedical Inc. (OTCQB: ENTB), a publicly traded biotechnology company focused on veterinary medicine. The Company seeks to develop small molecule and immune stimulating therapies for veterinary applications.

Currently, the Company's major interest is in developing small molecule therapies for treating cancer and autoimmune diseases in animals, which include arthritis.

Zander Therapeutics Inc. is the exclusive licensee for veterinary applications of Regen BioPharma Inc.'s (OTCQB: RGBP) (OTCQB: RGBPP) intellectual property and technology relating to NR2F6. NR2F6 is a molecular switch known as an "orphan nuclear receptor", which controls genes associated with the immune response. Zander Therapeutics is solely focused on veterinary applications.

David Koos serves as Chairman and Chief Executive officer of Regen BioPharma, Inc. (OTCQB: RGBP), Entest BioMedical Inc. (OTCQB: ENTB) and Zander Therapeutics Inc. (subsidiary of Entest BioMedical Inc.).

Disclaimer: This news announcement may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

CONTACT INFORMATION


Zander Therapeutics Inc. and Entest BioMedical Inc.
David R. Koos, Ph.D.
Chairman & Chief Executive Officer
619-702-1404 Phone
619-330-2328 Fax

http://www.zandertherapeutics.com/
My Favorite plays are on the Nasdaq DIP and RIP Board http://investorshangout.com/NASDAQ-DIP-and-RIP-87909/
My Favorite Paid chat room with amazing chart setups is The Trading Stock Lounge http://www.thetradingstocklounge.com/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 217

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 183

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 304

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 201

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 274

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 308

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 214

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 162

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 175

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 411

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading

Top 5 Most Recently Viewed Articles

Winston & Strawn Welcomes Adam Howard as New Partner in London

Updated Category News Views 969

Winston & Strawn Welcomes Adam Howard as Partner Winston & Strawn LLP is thrilled to announce the addition of Adam Howard to its Transactions Department in London as a partner. He will also serve as co-chair of the UK Capital Markets and Public Company Transactions Practice. This strategic move is expected to enhance the firm's expertise in capital markets and complex...

Continue Reading
Garmin Celebrates Inspirational Women in Sports and Aviation

Updated Category News Views 253

Honoring Women in Sports and Aviation this International Women's Day Garmin is delighted to recognize and celebrate the remarkable contributions of women who are making strides across various fields, including sports, aviation, and outdoors. This International Women's Day, Garmin spotlights female athletes and ambassadors whose achievements inspire others and showcase the...

Continue Reading
Maximizing Your Trading Strategy with Key Tech Stocks

Updated Category News Views 350

Understanding Market Dynamics for Effective Trading Good Morning Traders! Today’s trading session holds the potential for significant market movements due to the release of critical economic data. Earlier, we learned about specific metrics that reflect consumer behavior, labor market conditions, and inflation concerns, helping traders gauge potential impacts on market...

Continue Reading
Applied Digital Corp Looks to Break New Ground with PF-2 Plans

Updated Category News Views 196

Applied Digital Corp's Optimistic Future Applied Digital Corp (NASDAQ: APLD) has garnered attention after a recent report showed stronger-than-expected quarterly revenues, leading analysts to reassess the company's future prospects. Especially notable is the focus on Polaris Forge 2 (PF-2), a key aspect of the company's strategic plan going forward. Analyst...

Continue Reading
DDB Capital's New Community Project Set to Transform Athens

Updated Category News Views 258

DDB Capital Unveils Ambitious Community Plans DDB Capital Fund, LLC is thrilled to announce its recent approval for a 255-home community development, showcasing its commitment to enhancing quality living in strategic locations. This initiative comes at a pivotal time, coinciding with increased demands as U.S. Space Command relocates its headquarters, promoting regional...

Continue Reading